K Number
K050696
Device Name
MEDLITE C1 Q-SWITCHED ND:YAG LASER
Date Cleared
2005-06-17

(91 days)

Product Code
Regulation Number
878.4810
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Treatment of Pigmented Lesions Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology
Device Description
Not Found
More Information

Not Found

No
The summary describes a laser device for dermatological procedures and contains no mention of AI, ML, image processing, or performance studies typically associated with AI/ML devices.

Yes
Explanation: The device is a laser intended for the treatment of pigmented lesions, incision, excision, ablation, and vaporization of soft tissue for general dermatology, which are all therapeutic actions.

No
The intended use focuses on treatment procedures (incision, excision, ablation, vaporization, treatment of lesions), not diagnosis. It is a laser for surgical/therapeutic use.

No

The device is described as a "Q-Switched Nd:YAG Laser," which is a hardware device that emits laser light for treatment. The 510(k) summary does not mention any software component as the primary or sole function of the device.

Based on the provided information, the MedLite™ C1 Q-Switched Nd:YAG Laser is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states "Treatment of Pigmented Lesions Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology." This describes a device used for direct treatment of the patient's body, not for testing samples taken from the body (which is the core function of an IVD).
  • Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Providing diagnostic information based on sample analysis
    • Using reagents or assays

IVDs are devices used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The MedLite™ C1 is a laser used for surgical and dermatological procedures directly on the patient.

N/A

Intended Use / Indications for Use

The MedLite™ C1 Q-Switched Nd:YAG Laser is intended for: Treatment of Pigmented Lesions Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology

Product codes (comma separated list FDA assigned to the subject device)

GEX

Device Description

The MedLite™ C1 Q-Switched Nd:YAG Laser maintains the same fundamental technology and intended uses (at 532 nm) as its legally marketed predicate device, the MedLite™ C3 Q-Switched Nd:YAG Laser.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Nonclinical Performance Data: None Clinical Performance Data: None

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

MedLite™ C3 Q-Switched Nd:YAG Laser

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

0

JUN 17 2005

KA50696, p. 1 of 1

9. 510(k) Summary

| Company: | HOYA ConBio (formerly Continuum Electro-Optics, Inc.)
47733 Fremont Blvd
Fremont, CA 94538
(800) 532-1064 phone
(510) 445-4550 fax |
|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | Jim Green
Vice President of Engineering |
| Device Trade Name: | MedLite™ C1 Q-Switched Nd:YAG Laser |
| Common Name: | Medical Laser System |
| Classification Name: | Instrument, surgical, powered, laser |
| Classification Code: | 79-GEX |
| Equivalent Device(s): | MedLite™ C3 Q-Switched Nd:YAG Laser |
| Intended Use: | The MedLite™ C1 Q-Switched Nd:YAG Laser is intended for:
Treatment of Pigmented Lesions Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology |
| Comparison: | The MedLite™ C1 Q-Switched Nd:YAG Laser maintains the same
fundamental technology and intended uses (at 532 nm) as its
legally marketed predicate device, the MedLite™ C3 Q-Switched
Nd:YAG Laser. |
| Nonclinical Performance
Data: | None |
| Clinical Performance Data: | None |
| Additional Information: | None |

.

.

.

:

.

.

1

Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized emblem consisting of three abstract human figures or profiles facing to the right, with flowing lines suggesting movement or connection.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUN 17 2005

Mr. Jim Green Vice President of Engineering Hoya Photonics Incorporated 47733 Fremont Boulevard Fremont, California 94538

Re: K050696

Trade/Device Name: MedLite™ C' Q-Switched Nd: YAG Laser Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: March 16, 2005 Received: March 21, 2005

Dear Mr. Green:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

2

Page 2 - Mr. Jim Green

This letter will allow you to begin marketing your device as described in your Section 510(k) I his letter will anow you to begin maneting your arrantial equivalence of your device to a legally premarket notification. "The I DTC Intamged basification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific acvice ior your acc (240) 276-0115 . Also, please note the regulation entitled, Comact the Office of Comphalled at (21 the Part 807.97). You may obtain Misolanding by release to premainter to premainter the Act from the Division of Small other general information on your response Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

R. A. M.

Miriam C. Provost, Ph.D. Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

6. Indications for Use Statement

510(k) Number:

K050696

Device Name:

MedLite™ C' Q-Switched Nd:YAG Laser

Indications for Use:

  • Treatment of pigmented lesions .
    .

  • Incision, excision, ablation, vaporization of soft tissue . for general dermatology
    Prescription Use __ X (21 CFR 801 Subpart D)

OR

Over-the-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

ﻟﻜﻦ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍ .. 1000 Division of General, Restorative and Neurelogical Devices

K050696

6